V Nikolayevskyy
Overview
Explore the profile of V Nikolayevskyy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Papaventsis D, Casali N, Kontsevaya I, Drobniewski F, Cirillo D, Nikolayevskyy V
Clin Microbiol Infect
. 2016 Sep;
23(2):61-68.
PMID: 27665704
Objectives: We conducted a systematic review to determine the diagnostic accuracy of whole genome sequencing (WGS) of Mycobacterium tuberculosis for the detection of resistance to first- and second-line anti-tuberculosis (TB)...
12.
Stagg H, Harris R, Hatherell H, Obach D, Zhao H, Tsuchiya N, et al.
Thorax
. 2016 Jun;
71(10):940-9.
PMID: 27298314
Introduction: Consensus on the best treatment regimens for patients with isoniazid-resistant TB is limited; global treatment guidelines differ. We undertook a systematic review and meta-analysis using mixed-treatment comparisons methodology to...
13.
Toit K, Mitchell S, Balabanova Y, Evans C, Kummik T, Nikolayevskyy V, et al.
Int J Tuberc Lung Dis
. 2012 Jul;
16(8):1113-8.
PMID: 22762424
Setting: Tartu, Estonia. Objective: To assess the performance and feasibility of the introduction of the thin-layer agar MDR/XDR-TB Colour Test (Colour Test) as a non-commercial method of drug susceptibility testing...
14.
Drobniewski F, Nikolayevskyy V, Balabanova Y, Bang D, Papaventsis D
Int J Tuberc Lung Dis
. 2012 Jun;
16(7):860-70.
PMID: 22687497
This is an exciting time for tuberculosis (TB) diagnostics. The technology for rapid diagnosis of TB and rifampicin (RMP) resistance in pulmonary sputum smear-positive specimens is well advanced, and assays...
15.
Mironova S, Pimkina E, Kontsevaya I, Nikolayevskyy V, Balabanova Y, Skenders G, et al.
Eur J Clin Microbiol Infect Dis
. 2011 Nov;
31(7):1381-7.
PMID: 22037774
Former Soviet Union countries including the Baltic States (Latvia, Lithuania, and Estonia) are hot spots for an emerging epidemic of drug resistant tuberculosis (TB). As a part of the development...
16.
Kontsevaya I, Mironova S, Nikolayevskyy V, Balabanova Y, Mitchell S, Drobniewski F
J Clin Microbiol
. 2011 Jun;
49(8):2832-7.
PMID: 21632897
The Russian Federation is a high-tuberculosis (TB)-burden country with high rates of drug resistance, including multidrug and extensive drug resistance to TB (M/XDRTB). Rapid diagnosis of resistance to fluoroquinolones (FQs)...
17.
Drobniewski F, Nikolayevskyy V, Hoffner S, Pogoryelova O, Manissero D, Ozin A
Euro Surveill
. 2008 Sep;
13(12).
PMID: 18761994
National reference laboratories (NRL) and other laboratories are the cornerstones of well-functioning tuberculosis programmes and surveillance activities. However, the scope and activity of NRL services for mycobacterial identification and drug...
18.
Balabanova Y, Drobniewski F, Fedorin I, Zakharova S, Nikolayevskyy V, Atun R, et al.
Respir Res
. 2006 Mar;
7:44.
PMID: 16556324
Background: The World Health Organisation (WHO) defines Russia as one of the 22 highest-burden countries for tuberculosis (TB). The WHO Directly Observed Treatment Short Course (DOTS) strategy employing a standardised...